Simultaneous partial splenectomy during liver transplantation for advanced cirrhosis patients combined with severe splenomegaly and hypersplenism

Table 1 Preoperative characteristics

	LT group (n = 43)	PSLT group (n = 41)	P value
Gender (male/female)	27/16	28/13	0.651
Age, yr	49.2 ± 12.8	52.7 ± 13.1	0.219
Indication for transplantation
Hepatitis B cirrhosis	19	21	0.662
Hepatic malignancy	10	8	0.792
Alcoholic cirrhosis	8	6	0.772
Autoimmune liver disease	2	3	0.672
etc.	4	3	> 0.99
MELD score at transplantation	19.4 ± 4.9	20.7 ± 4.6	0.214
PreOP biology
Total bilirubin (μmol/L)	133.0 ± 106.9	128.5 ± 97.2	0.841
Serum creatinine (μmol/L)	96.1 ± 72.6	82.6 ± 66.3	0.377
INR	1.6 ± 0.6	1.7 ± 0.6	0.447
Plasma ammonia (μmol/L)	59.7 ± 21.5	57.6 ± 23.4	0.669
PreOP platelet count, 103/mm3	38.6 ± 14.7	36.9 ± 14.1	0.590
PreOP spleen volume, cm3	1665 ± 611	1711 ± 682	0.745
PreOP PV flow, cm/s	12.4 ± 3.9	11.8 ± 3.7	0.472
PreOP HA flow, cm/s	40.3 ± 22.1	40.9 ± 21.7	0.453

LT: Liver transplantation; PSLT: Partial splenectomy during liver transplantation; HA: Hepatic artery; PV: Portal vein; MELD: Model for End-Stage Liver Disease; INR: International normalized ratio; PreOP: Preoperative.